HeartGenetics is a biotech company that developed "solutions in a box”, including genetic tests and computational tools designed to support clinical diagnosis and the prevention of cardiovascular diseases.

‍

Armilar exited HeartGenetics on a trade sale with Impact Lab Group in November, 2020.